Earnings History Data for AnaptysBio (ANAB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

AnaptysBio

AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
05-11-2024	AH		ANAB	AnaptysBio	595.00	-1.14	-1.72	0.00	AnaptysBio GAAP EPS of -$1.14 beats by $0.51, revenue of $30.02M beats by $21.85M [11/5/2024 4:54 PM]	22.05	2.17 (10.92%)	21.99	2.11 (10.61%)	13.36 - 41.31	549,754	820,000	4,640
AnaptysBio GAAP EPS of -$1.14 beats by $0.51, revenue of $30.02M beats by $21.85M [11/5/2024 4:54 PM] Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update [2024-11-05 04:15PM] Anaptys Announces Participation in November and December Investor Conferences [2024-11-05 04:15PM] AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates [2024-11-05 05:30PM]
11-03-2024	AH		ANAB	AnaptysBio	655.00	-1.59	-1.74	0.00	AnaptysBio GAAP EPS of -$1.59 [3/11/2024 4:52 PM]	26.21	2.86 (12.25%)	25.72	2.37 (10.15%)	13.36 - 27.50	454,387	200,000	613
AnaptysBio GAAP EPS of -$1.59 [3/11/2024 4:52 PM] Wedbush raises AnaptysBio to outperform, cites upcoming data [3/12/2024 1:11 PM]
02-11-2023	AH		ANAB	AnaptysBio	433.00	-1.41	-1.72	0.00	AnaptysBio GAAP EPS of -$1.41 beats by $0.41, revenue of $3.32M beats by $1.84M [11/2/2023 5:43 PM]	17.50	1.30 (8.06%)	16.20	0.0 (0.00%)	15.88 - 32.44	174,432	230,000	5,793
AnaptysBio GAAP EPS of -$1.41 beats by $0.41, revenue of $3.32M beats by $1.84M [11/2/2023 5:43 PM]
07-08-2023	AH		ANAB	AnaptysBio	506.00	-1.50	-1.65	0.00	AnaptysBio GAAP EPS of -$1.50 beats by $0.20, revenue of $3.46M beats by $0.69M [8/7/2023 5:14 PM]	18.93	0.47 (2.55%)	19.00	0.54 (2.93%)	16.66 - 32.44	2,038,930	210,000	2,917
AnaptysBio GAAP EPS of -$1.50 beats by $0.20, revenue of $3.46M beats by $0.69M [8/7/2023 5:14 PM]
01-03-2023	AH	4:05 PM ET (Mar 1)	ANAB	AnaptysBio	699.00	-0.93	-0.92	0.00	AnaptysBio GAAP EPS of -$0.93, revenue of $6.8M [3/1/2023 5:39 PM]	24.73	-0.41 (-1.63%)	25.14	0.0 (0.00%)	18.20 - 32.44	193,157	220,000	1,660
AnaptysBio GAAP EPS of -$0.93, revenue of $6.8M [3/1/2023 5:39 PM]
08-11-2022	AH	4:05 PM ET (Nov 8)	ANAB	AnaptysBio	838.00	-1.18	-0.47	0.00	AnaptysBio GAAP EPS of -$1.18 misses by $0.56, revenue of $1.29M misses by $12.14M [11/8/2022 4:59 PM]	29.43	-0.14 (-0.47%)	29.14	-0.43 (-1.45%)	18.20 - 37.40	86,370	180,000	4,227
AnaptysBio GAAP EPS of -$1.18 misses by $0.56, revenue of $1.29M misses by $12.14M [11/8/2022 4:59 PM] AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update [Nov-08-22 04:05PM] AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Misses Revenue Estimates [Nov-08-22 05:55PM]
04-05-2022	AH	After the close (May 4)	ANAB	AnaptysBio, Inc.	647.53	-1.31	-0.87	-0.66	AnaptysBio GAAP EPS of -$1.31 misses by $0.32, revenue of $0.97M misses by $4.08M [5/4/2022 5:41 PM]	21.60	-2.73 (-11.22%)	23.93	-0.40 (-1.64%)	20.56 - 37.89	313,190	350,000	3,301
AnaptysBio GAAP EPS of -$1.31 misses by $0.32, revenue of $0.97M misses by $4.08M [5/4/2022 5:41 PM] AnaptysBio Announces First Quarter 2022 Financial Results and Provides Pipeline Update [May-04-22 04:15PM] AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Lags Revenue Estimates [May-04-22 06:55PM]
07-03-2022	PM	Before the open (Mar 7)	ANAB	AnaptysBio	828.00	-1.13	2.28	0.00		29.58	-0.67 (-2.21%)	29.78	-0.47 (-1.55%)	17.72 - 37.89	29,508	130,000	900
AnaptysBio Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Pipeline Update [Mar-07-22 08:50AM] AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Lags Revenue Estimates [Mar-07-22 10:05AM]
04-11-2021	AH	4:05 PM ET (Nov 4)	ANAB	AnaptysBio, Inc.	878.42	-0.24	-0.74	-0.87	AnaptysBio EPS beats by $0.64, beats on revenue [11/4/2021 5:08 PM]	37.06	2.57 (7.45%)	34.49	0.0 (0.00%)	17.72 - 37.63	233,858	220,000	1,218
AnaptysBio EPS beats by $0.64, beats on revenue [11/4/2021 5:08 PM] AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates [Nov-04-21 06:35PM] AnaptysBio Announces Third Quarter 2021 Financial Results and Provides Pipeline Updates [Nov-04-21 04:05PM]
04-05-2021	AH	4:05 PM ET (May 4)	ANAB	Anaptysbio, Inc.	639.00	-0.66	-0.71	0.00	AnaptysBio EPS beats by $0.03, beats on revenue [5/4/2021 5:12 PM]	24.48	0.98 (4.17%)	24.10	0.60 (2.55%)	13.92 - 35.85	309,080	260,000	1,129
AnaptysBio EPS beats by $0.03, beats on revenue [5/4/2021 5:12 PM] AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates [May-04-21 04:05PM] AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Misses Revenue Estimates [May-04-21 05:35PM]